ANIXA BIOSCIENCES INC (ANIX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is ANIXA BIOSCIENCES INC (ANIX) one of those stocks right now? A ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Anixa Biosciences, Inc (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Board of Directors has authorized a share repurchase program ...

On Monday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a key patent application covering Anixa Biosciences, Inc.’s (NASDAQ:ANIX) ovarian cancer vaccine ...

Anixa Biosciences Inc. Annual cash flow by MarketWatch. View ANIX net cash flow, operating cash flow, operating expenses and cash dividends.